Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Breast (Edinburgh, Scotland)|November 22, 2017
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancerSamuel Martel, Elena Poletto, Arlindo R Ferreira, et al.
Breast (Edinburgh, Scotland)|November 13, 2016
Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysisMarta Bonotto, Lorenzo Gerratana, Massimo Di Maio, et al.
Cancers|August 28, 2019
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic BiomarkerGiacomo Pelizzari, Debora Basile, Silvia Zago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd TrialAmelia McCartney, Martina Bonechi, Francesca De Luca, et al.
Breast (Edinburgh, Scotland)|April 3, 2021
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world studyDebora Basile, Lorenzo Gerratana, Carla Corvaja, et al.
Frontiers in Oncology|June 24, 2022
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?Lucia Bortot, Giada Targato, Claudia Noto, et al.
Breast (Edinburgh, Scotland)|February 6, 2026
Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 studyClaudia Noto, Lorenzo Foffano, Fabiola Giudici, et al.
Translational Oncology|June 27, 2025
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomicsLorenzo Foffano, Alessandra Franzoni, Elisabetta Molteni, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2025
Postoperative Single-Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer With GammaPod Technology: A Phase 2 Clinical TrialGiuseppe Facondo, Chiara Reverberi, Agnese Prisco, et al.
Scientific Reports|April 26, 2020
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosisLorenzo Gerratana, Debora Basile, Barbara Toffoletto, et al.
Pageof 5